Brean Initiates Alder BioPharma At Buy, $45 Price Target
April 20, 2016 at 09:46 AM EDT
Alder Biopharmaceuticals Inc (NASDAQ: ALDR) reported positive Phase 2b results for its lead product candidate ALD403, a novel ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.